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Preparations on Serial Peripheral Perfusion
Index and Tissue Carbon Monoxide
Measurements in Preterm Infants with Severe
Respiratory Distress SyndromeRespiratory distress syndrome (RDS) is a major cause of
morbidity and mortality in preterm infants, and exogenous
surfactant supplemental therapy is one of the standard
treatments. Peripheral perfusion index (PI) and trans-
cutaneous carbon monoxide (TCO) can be measured non-
invasively and provide indirect information on the
circulatory and pulmonary conditions in critical patients.
However, their clinical roles in high-risk premature infants
require evidence-based proof. Recently, Terek et al1 re-
ported their investigations regarding the use of serial PI and
TCO measurements in critical preterm infants who were
treated with different preparations of surfactants (poractant
alfa and beractant). They found some promising results and
concluded that noninvasive monitoring of PI and TCO as
markers of peripheral perfusion and lung function may be
useful for monitoring and follow up of high-risk neonates.
Extremely premature infants suffering from surfactant
deficiency and RDS are not rare, and RDS is a major cause of
morbidity and mortality in preterm infants. Exogenous
surfactant supplemental therapy is known to improve pul-
monary outcome and reduce mortality effectively.2 To
further improve the outcome, new exogenous surfactant
preparations in treating RDS are continuously being inves-
tigated. Furthermore, different strategies of surfactant
administration are also being tested to optimize patient
outcome.3 Currently, animal-derived surfactants, such as
porcine surfactant (poractant alfa) and bovine surfactants
(beractant and calfactant), are available for clinical use.4
Early selective surfactant administration to infants with
RDS requiring assisted ventilation was found to decrease
the risk of pulmonary complications, mortality, and chronic
lung disease compared to delaying treatment of such in-
fants until they developed a more severe case of RDS.5http://dx.doi.org/10.1016/j.pedneo.2015.03.004
1875-9572/Copyright ª 2015, Taiwan Pediatric Association. Published bHowever, changes in circulatory and pulmonary conditions
of high-risk preterm infants immediately following surfac-
tant treatment have been rarely investigated.
To continuously monitor patients’ conditions, noninvasive
monitors are better choices for critical neonates. Peripheral
PI is the ratio of the pulsatile to the nonpulsatile blood flow
in peripheral tissue. It provides indirect information on the
circulatory condition of vital organs, and it is a convenient
way to continuously monitor critical patients simply by using
a pulse oximeter.6 TCO correlates with the production of
internal carbon monoxide (CO), that usually increases when
the body is under oxidative stress and inflammation. RDS is
associated with pulmonary inflammation and may induce
upregulation of pro- and anti-inflammatory cytokines, lead-
ing to increases in CO production. End-tidal COmeasurement
has been used to predict the development of broncho-
pulmonary dysplasia in premature infants,7 but its clinical
role and the use of TCO monitoring require further studies.
Because both PI and TCO were not commonly used in
neonatal intensive care units, investigations are required to
elucidate their roles in high-risk preterm infants.
Recently, Terek et al1 compared the clinical response of
beractant and poractant alfa in treating premature infants
with RDS by using the noninvasive monitoring of PI and TCO.
They demonstrated that preterm infants with severe RDS
had significantly lower PI and higher TCO levels than control
infants, and that surfactant administration improved pa-
tients’ peripheral perfusion and decreased the severity of
pulmonary disease and oxidative and inflammatory stress.
Comparing different surfactants, they found that PI
improvement was seen earlier in the beractant rather than
the poractant alfa subgroup. TCO declined in both study
groups and were normalized earlier with poractant alfa.1 Toy Elsevier Taiwan LLC. All rights reserved.
212 Editorialthe best of our knowledge, this is the first study to use serial
PI and TCO measurements after surfactant administration
and to compare the influence on peripheral perfusion and
oxidative stress of different surfactant preparations in high-
risk preterm infants. According to the results, noninvasive
monitoring of PI and TCO as markers of peripheral perfusion
and lung function is useful for continuous monitoring and
follow up of high-risk preterm infants.
Conflicts of interest
The author declares no conflicts of interest.
Mei-Jy Jeng*
Institute of Emergency and Critical Care Medicine and
Department of Pediatrics, School of Medicine, National
Yang-Ming University, Taipei, Taiwan, ROC
Department of Pediatrics, Taipei Veterans General
Hospital, Taipei, Taiwan, ROC
* Institute of Emergency and Critical Care Medicine and
Department of Pediatrics, School of Medicine, National
Yang-Ming University, No.155, Sec.2, Linong Street,
Taipei 112, Taiwan, ROC.
E-mail address: mjjeng@vghtpe.gov.tw
Mar 17, 2015References
1. Terek D, Gonulal D, Koroglu OA, Yalaz M, Akisu M, Kultursay N.
Effects of two different exogenous surfactant preparations on
serial peripheral perfusion index and tissue carbon monoxide
measurements in preterm infants with severe respiratory
distress syndrome. Pediatr Neonatol 2015;56:248e55.
2. Polin RA, Carlo WA, Committee on Fetus and Newborn; Amer-
ican Academy of Pediatrics. Surfactant replacement therapy
for preterm and term neonates with respiratory distress. Pe-
diatrics 2014;133:156e63.
3. Speer CP, Sweet DG, Halliday HL. Surfactant therapy: past,
present and future. Early Hum Dev 2013;89:S22e4.
4. Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus
bovine surfactants for preterm newborns with respiratory
distress syndrome: systematic review and meta-analysis. Pe-
diatrics 2011;128:e1588e95.
5. Bahadue FL, Soll R. Early versus delayed selective surfactant
treatment for neonatal respiratory distress syndrome.
Cochrane Database Syst Rev 2012;11:Cd001456.
6. Zaramella P, Freato F, Quaresima V, Ferrari M, Vianello A,
Giongo D, et al. Foot pulse oximeter perfusion index corre-
lates with calf muscle perfusion measured by near-infrared
spectroscopy in healthy neonates. J Perinatol 2005;25:
417e22.
7. May C, Patel S, Peacock J, Milner A, Rafferty GF, Greenough A.
End-tidal carbon monoxide levels in prematurely born infants
developing bronchopulmonary dysplasia. Pediatr Res 2007;61:
474e8.
